Novartis and Roche ordered to pay €30.9 million cartel fine
The Turkish Competition Authority has become the latest enforcer to fine pharmaceutical companies Novartis and Roche for colluding to exaggerate a drug's potential side effects to encourage users to purchase a more expensive one.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.